[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340194-105":59,"doc-detail-340194-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","survival-in-thyroid-cancer-in-sweden-from-1999-to-2018","Survival in Thyroid Cancer in Sweden From 1999 To 2018","","Survival in thyroid cancer across Sweden from 1999 to 2018 is analyzed using Swedish cancer registry data and relative survival methods. Survival improved for all thyroid cancer in 10-year periods, with a stronger female survival advantage than male survival. Female advantage also appeared within several histological subtypes despite low case numbers for rare types. Outcomes varied markedly: 5-year relative survival was 100% for follicular, 6.1% for anaplastic cancer. Poor prognosis clustered with T4 and M1 stages and with the anaplastic subtype.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/survival-in-thyroid-cancer-in-sweden-from-1999-to-2018/340194/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/survival-in-thyroid-cancer-in-sweden-from-1999-to-2018/340194.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What data and method were used to evaluate survival in thyroid cancer?","Question",{"text":112,"@type":113},"Cancer data were obtained from the Swedish cancer registry between 1999 and 2018 and analyzed using relative survival.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did thyroid cancer survival change over time in Sweden?",{"text":117,"@type":113},"Relative survival for all thyroid cancers improved when analyzed in 10-year periods.",{"name":119,"@type":110,"acceptedAnswer":120},"Which thyroid cancer stages and histological type were linked to poorer survival?",{"text":121,"@type":113},"Among clinical TNM classes, T4 and M1 were associated with decreased survival. Anaplastic cancer showed the poorest outcomes and most often presented at high T and M1 stages.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340194,1790163953,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Clinical Epidemiology Dovepress  \nopen access to scientific and medical research  \n Open Access Full Text Article ORIGINAL RESEARCH  \nSurvival in Thyroid Cancer in Sweden From 1999 To 2018  \nFrantisek Zitricky 1 , Anni Koskinen2 , 3 , Kristina Sundquist4–6 , Jan Sundquist 4–6 , Vaclav Liska 1 , 7 , Asta Försti 8 , 9 , Akseli Hemminki 10 , 11 , Kari Hemminki 1 ,4 , 12  \n1Biomedical Center, Faculty of Medicine, Charles University, Pilsen, Czech Republic; 2Department of Otorhinolaryngology- Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland; 3Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland; 4Center for Primary Health Care Research, Lund University, Malmö, Sweden; 5Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA; 6Center for Community-Based Healthcare Research and Education (Cohre), Department of Functional Pathology, School of Medicine, Shimane University, Shimane, Japan; 7Department of Surgery, Charles University Medical School, Pilsen, Czech Republic; 8Hopp Children’s Cancer Center (Kitz), Heidelberg, Germany; 9Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany; 10Cancer Gene Therapy Group, Translational Immunology Research Program, University of Helsinki, Helsinki, Finland; 11Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland; 12Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany  \nCorrespondence: Kari Hemminki, Biomedical Center, Faculty of Medicine, Charles University Pilsen, Pilsen, 30605, Czech Republic, Email [k.hemminki@dkfz.de](k.hemminki@dkfz.de)  \n\n| Introduction: Thyroid cancer (TC) is diagnosed in several histological types which differ in their clinical characteristics and survival. We aim to describe how they influence TC survival in Sweden.\u003Cbr>Methods: Cancer data were obtained from the Swedish cancer registry between years 1999 and 2018, and these were used to analyze relative survival.\u003Cbr>Results: Relative survival for all TC improved when analyzed in 10-year periods, and female survival improved more than male survival. Female survival advantage appeared to be present also for specific histological types, although case numbers were low for rare types. Female 5-year relative survival for TC was 100% for follicular, 95.1% for oncocytic, 93.4% for papillary, 89.7% for medullary, and 6.1% for anaplastic cancer. Among the clinical TNM classes, only T4 and M1 stages were associated with decreased survival compared to T1-3 and M0 . Anaplastic cancer presented most often at high T and M1 stages, in contrast to other TC. Curiously, the diagnostic age for anaplastic M1 patients was lower than that for M0 patients. Both anaplastic and medullary cancers did not show age-dependent increases in the probability of metastases, in contrast to the main histological types. This could indicate the presence of several types of anaplastic and medullary cancers.\u003Cbr>Conclusion: The poor survival for anaplastic TC is an extreme contrast to the excellent survival of differentiated TC. As less than 20% of anaplastic cancer patients survived one year, urgent diagnosis and initiation of treatment are important. Facilitated treatment pathways have been instituted in Denmark resulting in improved survival. Anaplastic cancer should be a target of a major research focus.\u003Cbr>Keywords: prognosis, relative survival, anaplastic cancer, metastasis, trends |\n| --- |\n| Introduction\u003Cbr>The thyroid gland constitutes two connected lobes and with a weight of 20 to 30 g it is among the largest endocrine glands in humans.1 Various types of thyroid lesions may be present at a prevalence of 4% to 7%, and most areasymptomatic without affecting hormone secretion of the gland.1 Thyroid cancer (TC) is the most","cbCain7tR01lqwQc","https://ap.wps.com/l/cbCain7tR01lqwQc","pdf",2158993,13,"English","# Introduction\n# Methods\n# Results\n# Conclusion\n# Keywords","[{\"question\":\"What data and method were used to evaluate survival in thyroid cancer?\",\"answer\":\"Cancer data were obtained from the Swedish cancer registry between 1999 and 2018 and analyzed using relative survival.\"},{\"question\":\"How did thyroid cancer survival change over time in Sweden?\",\"answer\":\"Relative survival for all thyroid cancers improved when analyzed in 10-year periods.\"},{\"question\":\"Which thyroid cancer stages and histological type were linked to poorer survival?\",\"answer\":\"Among clinical TNM classes, T4 and M1 were associated with decreased survival. Anaplastic cancer showed the poorest outcomes and most often presented at high T and M1 stages.\"}]","Survival in Thyroid Cancer in Sweden From 1999 To 2018 | PDF",1790034856,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d05affb576b7e6e929b52604c8881bef.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b6103db5ca035c5433cd96adfdb9bd8.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/feef64186327512094882e25c3440f76.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d65f9fd4e889a905c01b179f92a42a7c.webp",980,1268]